Skip to content
← Full study record

NCT01258998 · MORE INFO

Limitations, agreements, and source contact

Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma · Source last updated 2020-11-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
crflowers@mdanderson.org
organization
The University of Texas (UT) MD Anderson Cancer Center
phone
713- 745-6095
title
Christopher R Flowers,Chair, Lymphoma-Myeloma
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
crflowers@mdanderson.org
organization
The University of Texas (UT) MD Anderson Cancer Center
phone
713- 745-6095
title
Christopher R Flowers,Chair, Lymphoma-Myeloma

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice